Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Left Ventricular Dysfunction
Open-data reference.
8 US clinical trials · 3 currently recruiting
Active & Recent Trials
Sodium Lowering Vascular Effects Trial
Tulane University
NCT05388032
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Wake Forest University Health Sciences
NCT04752293
The JenaValve ALIGN-AR LVAD Registry
JenaValve Technology
NCT06594705
PRE-DETERMINE Cohort Study
Brigham and Women's Hospital
NCT01114269
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
Abiomed
NCT04763200
IMpella-Protected cArdiaC Surgery Trial (IMPACT)
Abiomed
NCT05529654
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
GE Healthcare
NCT01076296
Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study)
The University of Texas Health Science Center, Houston
NCT00684021
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Left Ventricular Dysfunction Trial Landscape
ClinicalTrials.gov lists 8 US studies indexed under Left Ventricular Dysfunction, and 3 of those are currently open to recruitment — roughly 38% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Left Ventricular Dysfunction shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Left Ventricular Dysfunction is led by Abiomed with 2 indexed trials, alongside 6 other organizations in the top contributor list. The list on this page surfaces up to 8 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Left Ventricular Dysfunction?
PlainTrial tracks 8 US clinical trials for Left Ventricular Dysfunction, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Left Ventricular Dysfunction?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.